Cargando…

Gout Augments the Risk of Cardiovascular Disease in Patients With Psoriasis: A Population-Based Cohort Study

OBJECTIVE: Patients with psoriasis (PsO) have a high frequency of concomitant gout and increased risk of cardiovascular diseases (CVD). We aimed to estimate the synergistic impact of gout on the risk of CVD in patients with PsO. METHODS: A population-based cohort of patients registered in the Nation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhiyong, Xu, Yiwen, Chen, Miao, Cui, Ran, Wang, Yu-Hsun, Dai, Sheng-Ming, Wei, James Cheng-Chung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320695/ https://www.ncbi.nlm.nih.gov/pubmed/34335617 http://dx.doi.org/10.3389/fimmu.2021.703119

Ejemplares similares

The Risk of Gout in Patients with Psoriasis: A Population-Based Cohort Study in Taiwan
por: Wei, James Cheng-Chung, et al.
Publicado: (2022)

Perceptions of Rheumatologists on Diagnosis of Psoriatic Arthritis in China
por: Chen, Miao, et al.
Publicado: (2021)

Comments on the Risk of Gout in Patients with Psoriasis [Letter]
por: Yeh, Wen-Bin, et al.
Publicado: (2022)

Gout and the risk of epilepsy: A population-based cohort study
por: Chen, Hung-Lin, et al.
Publicado: (2020)

Psoriasis, Cardiovascular Events, and Biologics: Lights and Shadows
por: Caiazzo, Giuseppina, et al.
Publicado: (2018)

Platelet activation: a promoter for psoriasis and its comorbidity, cardiovascular disease
por: Jiang, Ziqi, et al.
Publicado: (2023)

Sarcoidosis, Psoriasis, and Gout: Syndrome or Coincidence?
por: Kaplan, Herbert, et al.
Publicado: (1960)

Chronic tophaceous gout in patients with psoriasis
por: Lobato, Laís Cruz, et al.
Publicado: (2017)

T Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular Comorbidities
por: Casciano, Fabio, et al.
Publicado: (2018)

Potential Immunological Links Between Psoriasis and Cardiovascular Disease
por: Sajja, Aparna P., et al.
Publicado: (2018)

Psoriasis and Cardiovascular Diseases: An Immune-Mediated Cross Talk?
por: Orlando, Gloria, et al.
Publicado: (2022)

Tophaceous Gout – Even Today
por: Polukhin, Elena, et al.
Publicado: (2013)

The Association Between Psoriasis and Risk of Cardiovascular Disease: A Mendelian Randomization Analysis
por: Gao, Ning, et al.
Publicado: (2022)

Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences
por: Boehncke, Wolf-Henning
Publicado: (2018)

IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
por: von Stebut, Esther, et al.
Publicado: (2020)

Risk of Ankylosing Spondylitis in Patients With Endometriosis: A Population-Based Retrospective Cohort Study
por: Yin, Zhihua, et al.
Publicado: (2022)

Anti-gout Medications and Risk of Cardiovascular Disease: A Nested Case-Control Study
por: Chuang, Tsung-Ju, et al.
Publicado: (2021)

Editorial: Advances in Pathogenesis and Therapies of Gout
por: Duan, Lihua, et al.
Publicado: (2022)

The Role of Advanced Imaging in Gout Management
por: Li, Shuangshuang, et al.
Publicado: (2022)

Neutrophils in Psoriasis
por: Chiang, Chih-Chao, et al.
Publicado: (2019)

A nomogram diagnostic cardiovascular disease in patients with erythrodermic psoriasis in Chinese
por: Zou, Yue-Min, et al.
Publicado: (2023)

Association Between Use of Anti-gout Preparations and Dementia: Nested Case–Control Nationwide Population-Based Cohort Study
por: Chuang, Tsung-Ju, et al.
Publicado: (2021)

Increased the risk of heart failure and comorbidities in patients with gout treatment: a population-based cohort study
por: Chen, Hsin-Hung, et al.
Publicado: (2020)

Purinergic Signaling in the Regulation of Gout Flare and Resolution
por: Li, Xiaoling, et al.
Publicado: (2021)

Recent Insights Into the Role of Macrophages in Acute Gout
por: Liu, Lei, et al.
Publicado: (2022)

GPR105-Targeted Therapy Promotes Gout Resolution as a Switch Between NETosis and Apoptosis of Neutrophils
por: Liu, Chunxiao, et al.
Publicado: (2022)

Risk of gout attack not increased in patients with thalassemia: a population-based cohort study
por: Chen, Jing-Wen, et al.
Publicado: (2023)

Prevalence of psoriatic arthritis in Chinese population with psoriasis: A multicenter study conducted by experienced rheumatologists
por: Zhang, Hua, et al.
Publicado: (2023)

AIM2 and Psoriasis
por: Zhang, Yuxi, et al.
Publicado: (2023)

The roles of T cells in psoriasis
por: Zhang, Peng, et al.
Publicado: (2023)

Role of NLRP3 in the pathogenesis and treatment of gout arthritis
por: Liu, Ya-ru, et al.
Publicado: (2023)

Immunity: Psoriasis comorbid with atherosclerosis
por: Liu, Chunping, et al.
Publicado: (2022)

Research progress of risk factors and early diagnostic biomarkers of gout-induced renal injury
por: Wang, Sheng, et al.
Publicado: (2022)

Increased Risk of Inflammatory Bowel Disease Among Patients With Ankylosing Spondylitis: A 13-Year Population-Based Cohort Study
por: Wang, Shuya, et al.
Publicado: (2020)

Risk of Psoriasis in Patients with Polycystic Ovary Syndrome: A National Population-Based Cohort Study
por: Lee, Tsung-Hsien, et al.
Publicado: (2020)

The Anti-Inflammatory and Uric Acid Lowering Effects of Si-Miao-San on Gout
por: Cao, Ling, et al.
Publicado: (2022)

Risk of psoriasis in people with hidradenitis suppurativa: A systematic review and meta-analysis
por: Gau, Shuo-Yan, et al.
Publicado: (2022)

Identification of Inflammation-Related Biomarker Pro-ADM for Male Patients With Gout by Comprehensive Analysis
por: Qiu, Kangli, et al.
Publicado: (2022)

Expansion of Polymorphonuclear Myeloid-Derived Suppressor Cells in Patients With Gout
por: Zhong, Limei, et al.
Publicado: (2020)

Presence of tophi and carotid plaque were risk factors of MACE in subclinical artherosclerosis patients with gout: a longitudinal cohort study
por: Wang, Yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7akajvo4s8ok8iedno240joe86